Deep-Dive Due Diligence AI Generated Report on Tenon Medical, Inc. Common Stock (TNON)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.


TNON_OUT_1 [2025-03-25 06:25:59 -0400] 1974 Bytes | 561 tokens | Cum: 561 tkns (7.01% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 6:25:56 AM on Tue Mar 25, 2025 -0400, and I'm firing up the spotlight on Tenon Medical (TNON), moving from 0.9781 to 2.78. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

Here's the first list of news for Tenon Medical:

C1 - Mar-24-25 04:05PM - Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
C2 - Mar-20-25 06:40PM - Tenon Medical, Inc. (TNON) Q4 2024 Earnings Call Transcript
C3 - Mar-20-25 06:40PM 04:05PM - Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results
C4 - Mar-11-25 03:40PM - Tenon Medical, Inc. Announces a Warrant Inducement Transaction for $3.0 Million in Gross Proceeds
C5 - Mar-10-25 04:05PM - Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
C6 - Mar-07-25 08:00AM - Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
C7 - Jan-09-25 08:00AM - Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
C8 - Nov-13-24 04:05PM - Tenon Medical Reports Third Quarter 2024 Financial Results

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Tenon Medical (TNON)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

TNON_IN_2 [2025-03-25 06:25:59 -0400] 2 Bytes | 2 tokens | Cum: 563 tkns (7.04% of 8k)
==========================================================================

C1

TNON_OUT_3 [2025-03-25 06:26:04 -0400] 493 Bytes | 144 tokens | Cum: 707 tkns (8.84% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion**
Date: Mar-24-25 04:05PM
Source: (ACCESSWIRE)
URL: https://www.accesswire.com/viewarticle.aspx?id=1004697

Error fetching article: 403 Client Error: Forbidden for url: https://www.accesswire.com/viewarticle.aspx?id=1004697

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TNON_IN_4 [2025-03-25 06:26:05 -0400] 458 Bytes | 87 tokens | Cum: 794 tkns (9.93% of 8k)
==========================================================================

As a financial analyst, I'm unable to provide a summary or evaluation of the situation due to lack of information. The only information available is that Tenon Medical has received FDA clearance for a new indication of its Catamaran SI Joint Fusion System to augment spinal fusion. For a proper analysis, we would need more details about the potential market impact, projected sales, and how this FDA clearance might affect Tenon Medical's financial outlook.

TNON_OUT_5 [2025-03-25 06:26:06 -0400] 1008 Bytes | 304 tokens | Cum: 1098 tkns (13.73% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-24T21:05:45Z - 12 Health Care Stocks Moving In Monday's After-Market Session - Aspira Womens Health (NASDAQ:AWH), C...
A2 - 2025-03-24T20:14:00Z - Tenon Medical, Inc.: Tenon Medical Announces FDA Clearance of Catamaran SI Joint Fusion System for N...
A3 - 2025-03-24T20:21:25Z - Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication t...
A4 - 2025-03-24T20:14:43Z - Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication t...
A5 - 2025-03-20T20:28:00Z - Tenon Medical GAAP EPS of -$11.26, revenue of $3.28M misses by $0.13M...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

TNON_IN_6 [2025-03-25 06:26:06 -0400] 2 Bytes | 2 tokens | Cum: 1100 tkns (13.75% of 8k)
==========================================================================

A1

TNON_OUT_7 [2025-03-25 06:26:07 -0400] 1038 Bytes | 315 tokens | Cum: 1415 tkns (17.69% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Monday's After-Market Session - Aspira Womens Health (NASDAQ:AWH), Capstone Holding (NASDAQ:CAPS)**Date: 2025-03-24Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44466107/12-health-care-stocks-moving-in-mondays-after-market-sessionGainers Tenon Medical TNON shares rose 43.1% to $1.4 during Monday's after-market session. The company's market cap stands at $4.3 million. As per the news, the Q4 earnings report came out 2 days ago. Know Labs KNW shares rose 17.14% to $1.23. The market value of their outstanding shares is at $3.4 million. OneMedNet ONMD stock increased by 12.84% to $0.65. The market value of their outstanding shares is at $18.1 million. Polyrizon PLRZ shares moved upwards by 10.28% to $0.83. The market value of their outstanding shares is at $3.6 million. Intensi

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TNON_IN_8 [2025-03-25 06:26:07 -0400] 3 Bytes | 2 tokens | Cum: 1417 tkns (17.71% of 8k)
==========================================================================

MOR

TNON_OUT_9 [2025-03-25 06:26:09 -0400] 1038 Bytes | 316 tokens | Cum: 1733 tkns (21.66% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): ty Therapeutics INTS stock increased by 8.91% to $2.2. The company's market cap stands at $33.3 million. Citius Oncology CTOR stock rose 8.57% to $0.76. The company's market cap stands at $54.3 million. Losers Capstone Holding CAPS shares fell 13.4% to $2.4 during Monday's after-market session. The market value of their outstanding shares is at $3.3 million. Coeptis Therapeutics COEP shares fell 7.97% to $8.66. The company's market cap stands at $28.0 million. Radiopharm Theranostics RADX stock declined by 7.89% to $5.27. The market value of their outstanding shares is at $40.9 million. Aspira Womens Health AWH shares declined by 6.88% to $0.09. The market value of their outstanding shares is at $1.5 million. Gelteq GELS shares fell 6.55% to $1.0. The company's market cap stands at $9.4 million. Kindly MD KDLY stock declined by 5.86% to $2.09. The market value of their outstanding shares

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TNON_IN_10 [2025-03-25 06:26:09 -0400] 3 Bytes | 2 tokens | Cum: 1735 tkns (21.69% of 8k)
==========================================================================

MOR

TNON_OUT_11 [2025-03-25 06:26:14 -0400] 981 Bytes | 336 tokens | Cum: 2071 tkns (25.89% of 8k)
==========================================================================

Showing A1 (chunk 3 of 3): is at $12.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

AWHAspira Womens Health Inc$0.08800.11%Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock - anytime.

Reveal Full ScoreEdge RankingsMomentum0.72Growth32.75Quality-Value36.25Price TrendShortMediumLongOverviewCAPSCapstone Holding Corp$2.6453.5%COEPCoeptis Therapeutics Holdings Inc$8.66-8.83%CTORCitius Oncology Inc$0.760022.6%GELSGelteq Ltd$1.00-5.66%INTSIntensity Therapeutics Inc$2.2010.0%KDLYKindly MD Inc$2.1039.1%KNWKnow Labs Inc$1.264.13%ONMDOneMedNet Corp$0.649920.4%PLRZPolyrizon Ltd$0.777039.2%RADXRadiopharm Theranostics Ltd$5.27-7.56%TNONTenon Medical Inc$1.4141.0%Market News and Data brought to you by Benzinga APIs

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TNON_IN_12 [2025-03-25 06:26:14 -0400] 460 Bytes | 107 tokens | Cum: 2178 tkns (27.22% of 8k)
==========================================================================

This text provides information on various stocks and their current values and percentage changes, including Aspira Women's Health Inc, Capstone Holding Corp, Coeptis Therapeutics Holdings Inc, Citius Oncology Inc, Gelteq Ltd, Intensity Therapeutics Inc, Kindly MD Inc, Know Labs Inc, OneMedNet Corp, Polyrizon Ltd, Radiopharm Theranostics Ltd, and Tenon Medical Inc. The information is provided by Benzinga's automated content engine and reviewed by an editor.

TNON_OUT_13 [2025-03-25 06:26:16 -0400] 949 Bytes | 303 tokens | Cum: 2481 tkns (31.01% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-03-13T12:24:11Z - Why SurgePays Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
B2 - 2023-11-13T18:08:54Z - Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B3 - 2023-11-07T13:28:51Z - Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
B4 - 2023-11-03T17:26:11Z - Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
B5 - 2023-11-03T16:12:08Z - Dow Surges Over 200 Points; ISM Services PMI Falls In October
B6 - 2023-11-03T14:02:16Z - Nasdaq Gains 1%; US Adds 150,000 Jobs In October

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TNON_IN_14 [2025-03-25 06:26:16 -0400] 2 Bytes | 2 tokens | Cum: 2483 tkns (31.04% of 8k)
==========================================================================

B2

TNON_OUT_15 [2025-03-25 06:26:22 -0400] 1042 Bytes | 281 tokens | Cum: 2764 tkns (34.55% of 8k)
==========================================================================

Showing B2 (chunk 1 of 3): B2:
**Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/23/11/35758121/why-edible-garden-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-mondays-midEdible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.
Edible Garden posted a quarterly loss of 69 cents per share, compared to a year-ago loss of $7.20 per share, according to Benzinga Pro. The company’s quarterly sales came in at $3.29 million.
Edible Garden shares fell on Monday fell 17.6% to $0.5315 during Monday’s session.
Gainers

Tenax Therapeutics, Inc (NASDAQ: TENX) shares jumped 130% to $0.3588 after the company announced FDA clearance of IND for TNX-103 for the treatment of pulmonary hypertension with heart failure with preserv

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TNON_IN_16 [2025-03-25 06:26:22 -0400] 554 Bytes | 132 tokens | Cum: 2896 tkns (36.20% of 8k)
==========================================================================

Edible Garden AG Incorporated (NASDAQ: EDBL) has witnessed a decrease in share price of around 18%, which has been attributed to the company's recent third-quarter results. Despite narrowing its loss from $7.20 per share a year ago to 69 cents per share, the company's shares fell 17.6% to $0.5315. Edible Garden's quarterly sales were recorded at $3.29 million. Meanwhile, Tenax Therapeutics, Inc (NASDAQ: TENX) shares rose 130% after the company announced FDA clearance of IND for TNX-103 for the treatment of pulmonary hypertension with heart failure.

TNON_OUT_17 [2025-03-25 06:26:24 -0400] 1101 Bytes | 307 tokens | Cum: 3203 tkns (40.04% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-12 8-K Item 1.01. Entry into a Material Definitive Agrmt.

On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants...

S2 - 2025-03-12 8-K Item 1.01. Entry into a Material Definitive Agrmt.

On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants...

S3 - 2024-11-14 10-Q PART I FIN INFO

ITEM 1. Condensed Cons Fin Stmnts (Unaudited)

Tenon Medical, Inc.

Condensed Cons Balance Sheets (Unaudited)

(In thousands, except share data)

September 30, December 31, 2024 2023 Assets Curr assets: Cash and ca...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TNON_IN_18 [2025-03-25 06:26:24 -0400] 2 Bytes | 2 tokens | Cum: 3205 tkns (40.06% of 8k)
==========================================================================

S1

TNON_OUT_19 [2025-03-25 06:26:25 -0400] 1038 Bytes | 268 tokens | Cum: 3473 tkns (43.41% of 8k)
==========================================================================

Showing S1 (chunk 1 of 5): S1:
Item 1.01. Entry into a Material Definitive Agreement.

On March 11, 2025, Tenon Medical, Inc. (the Company) entered into a warrant exercise inducement offer letter agreement (the Inducement Letter) with a certain holder (the Holder) of outstanding Common Stock purchase warrants exercisable for up to an aggregate of 2,445,700 shares (the Existing Warrants) of the Companys common stock, par value $0.001 per share (the Common Stock), which Existing Warrants were issued by the Company on September 16, 2024, and were originally exercisable at an exercise price of $4.28 per share.

Pursuant to the Inducement Letter, the Holder agreed to exercise the Existing Warrants for cash at a reduced exercise price of $1.25 per share in consideration for the Companys agreement to issue (i) new unregistered five-year warrants (the Series C-1 Warrants) to purchase up to an aggregate of 2,445,700 share

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TNON_IN_20 [2025-03-25 06:26:26 -0400] 3 Bytes | 2 tokens | Cum: 3475 tkns (43.44% of 8k)
==========================================================================

MOR

TNON_OUT_21 [2025-03-25 06:26:27 -0400] 1038 Bytes | 252 tokens | Cum: 3727 tkns (46.59% of 8k)
==========================================================================

Showing S1 (chunk 2 of 5): s of Common Stock at an exercise price of $1.25 per share and (ii) new unregistered three-year warrants (the Series C-2 Warrants, and together with the Series C-1 Warrants, the New Warrants) to purchase up to an aggregate of 1,222,850 shares of Common Stock at an exercise price of $1.25 per share (the Inducement Transaction). The New Warrants are not exercisable without approval by our stockholders (Stockholder Approval), which, pursuant to the Inducement Letter, we are required to obtain at a meeting of our stockholders no later than 165 days after the consummation of the Inducement Transaction. The Series C-1 Warrants will be exercisable five years from the date on which Stockholder Approval is obtained, and the Series C-2 Warrants will be exercisable three years from the date on which Stockholder Approval is obtained.

The Company entered into a financial advisory agreement (the Fina

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TNON_IN_22 [2025-03-25 06:26:27 -0400] 3 Bytes | 2 tokens | Cum: 3729 tkns (46.61% of 8k)
==========================================================================

NEX

TNON_OUT_23 [2025-03-25 06:26:41 -0400] 4306 Bytes | 1233 tokens | Cum: 4962 tkns (62.02% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+-----------------------+---------------------+-----------------------+------------------------+-------------------------+
| Volume: 18,158,912 | SMA50: -32.31% | Market Cap: 3.07M | Option/Short: No / No | Sales past 5Y: 238.26% | Sales Surprise: -11.21% |
+--------------------+-----------------------+---------------------+-----------------------+------------------------+-------------------------+
| Avg Volume: 1.26M | SMA200: -70.49% | Shs Outstand: 3.14M | Short Float: 5.29% | Employees: 21 | EPS Surprise: 379.31% |
+--------------------+-----------------------+---------------------+-----------------------+------------------------+-------------------------+
| Rel Volume: 15.88 | Perf Week: -12.67% | Shs Float: 3.14M | Short Ratio: 0.13 | Debt/Eq: 0.07 | P/E: - |
+--------------------+-----------------------+---------------------+-----------------------+------------------------+-------------------------+
| RSI (14): 35.75 | Perf Month: -29.63% | Inst Own: 2.76% | Short Interest: 0.17M | Sales Y/Y TTM: 11.92% | Earnings: Mar 20 AMC |
+--------------------+-----------------------+---------------------+-----------------------+------------------------+-------------------------+
| ATR (14): 0.15 | Perf Quarter: -47.13% | Insider Own: 0.00% | Beta: 1.93 | ROE: -405.19% | |
+--------------------+-----------------------+---------------------+-----------------------+------------------------+-------------------------+
| SMA20: -19.71% | Index: - | Insider Trans: - | Sales Q/Q: -4.70% | ROI: -223.71% | |
+--------------------+-----------------------+---------------------+-----------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: Tenon Medical, Inc. Common Stock
Market Cap: 3067897.7009
Shares Outstanding: 3136589
Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 3315000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -13720000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.9781
Average Volume: 3312196.33
30-Day High: 1.51
30-Day Low: 0.9781

[Detailed Financials: Q3 2024]
- Total Assets: $13,039,000.0
- Total Liabilities: $4,848,000.0
- Total Equity: $8,191,000.0
- Current Assets: $11,188,000.0
- Current Liabilities: $3,178,000.0

[Income Statement: Q3 2024]
- Revenue: $887,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -3.63

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $7,194,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $6,006,000.0
- Total Liabilities: $5,174,000.0
- Total Equity: $832,000
- Current Assets: $4,087,000.0
- Current Liabilities: $3,403,000.0

[Income Statement: Q2 2024]
- Revenue: $901,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.02

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-2,420,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

TNON_IN_24 [2025-03-25 06:26:41 -0400] 1121 Bytes | 263 tokens | Cum: 5225 tkns (65.31% of 8k)
==========================================================================

1) Brief Summary:
Tenon Medical, Inc. is in a precarious financial situation. The share price has been consistently declining over the past quarter, month, and week, with SMA50 at -32.31% and SMA200 at -70.49%. The company's sales have also slipped by -4.7% Q/Q and significantly missed expectations by -11.21%. The company is also not generating positive earnings, as indicated by the negative P/E ratio and EPS of -3.63. On the positive side, the company has a relatively low debt/equity ratio of 0.07 and has seen a substantial increase in its sales over the past 5 years. However, it will need to reverse its current downward trends to restore investor confidence.

2) MARKET_SCORE: [30]

Given the negative financial indicators and recent performance, there is only a 30% chance of an upward movement in the company's share price.

3) PRICE_TARGET: [$1.00]

Considering the company's current performance and financial status, a modest increase in its current price of $0.9781 seems reasonable, suggesting a price target of $1.00.

4) AI_RPT_HEADLINE: ["Tenon Medical Struggles Amid Declining Sales and Share Price"]

TNON_OUT_25 [2025-03-25 06:26:43 -0400] 676 Bytes | 167 tokens | Cum: 5392 tkns (67.40% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

TNON_IN_26 [2025-03-25 06:26:44 -0400] 94 Bytes | 28 tokens | Cum: 5420 tkns (67.75% of 8k)
==========================================================================

-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes

TNON_IN_27 [2025-03-25 06:26:44 -0400] 126 Bytes | 29 tokens | Cum: 5449 tkns (68.11% of 8k)
==========================================================================

====================================
[2025-03-25 03:26:44] # Analysis Completed
Elapsed Time: 48.23 seconds




Scroll to Top